Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry

Fabiola Atzeni, Piercarlo Sarzi-Puttini, Costantino Botsios, Antonio Carletto, Paola Cipriani, Ennio Giulio Favalli, Elena Frati, Valentina Foschi, Stefania Gasparini, Annarita Giardina, Elisa Gremese, Florenzo Iannone, Marco Sebastiani, Tamara Ziglioli, Domenico Biasi, Clodoveo Ferri, Mauro Galeazzi, Roberto Gerli, Roberto Giacomelli, Roberto GorlaMarcello Govoni, Giovanni Lapadula, Antonio Marchesoni, Fausto Salaffi, Leonardo Punzi, Giovanni Triolo, Gianfranco Ferraccioli

Dipartimento di Scienze geriatriche e ortopediche
Facoltà di Medicina e Chirurgia "A.Gemelli"
Ambito disciplinare: Clinica Medica Specialistica

University of Milan
University of Padua
University of Verona
University of L'Aquila
Orthopedic Institute Gaetano Pini, Milan
University of Siena
University of Ferrara
Marche Polytechnic University
University of Palermo
University of Bari
University of Modena and Reggio Emilia
University of Brescia
University of Perugia

Risultato della ricerca: Contributo in rivista › Articolo in rivista

112 Citazioni (Scopus)

Ordina per
Peso
Alfabetico

Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry

Fingerprint

Pharmacology, Toxicology and Pharmaceutical Science